Alta Partners
Signal active
Investment Firm
Overview
Alta Partners is a venture capital firm investing in the healthcare and life sciences sector.
Their diverse and integrated team brings together a powerful depth of knowledge and experience, delivering tangible results for their companies and their investors.
Highlights
Founded
1996
Industry
Financial Services
Employees
11-50
Investment
274
Lead Investment
59
Exits
86
Stages
Late Stage Venture, Early Stage Venture, Private Equity, Seed
Investor Type
Venture Capital
Location
United States, North America
Contact Information
Social
Profile Resume
Alta Partners, established in 1996 and headquartered in United States, North America., specializes in Late Stage Venture, Early Stage Venture, Private Equity, Seed investments across Collaboration, Enterprise Software, Software, Knowledge Management, Venture Capital, Finance, Non Profit, Semiconductor, Product Design, Financial Services. The organization boasts a portfolio of 274 investments, with an average round size of $42.0M and 86 successful exits. Their recent investments include Tacit Software, In-Q-Tel, Xelerated, Amadeus Capital Partners, Accel. The highest investment round they participated in was $819.7B. Among their most notable exits are Tacit Software and In-Q-Tel. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.
Investment portfolio
Alta Partners has made 274 investments. Their most recent investment was on May 20, 2024, when Progentos Therapeutics raised $65.0M.
Alta Partners has made 52 diversity investments. Their most recent diversity investment was on Nov 14, 2023, when MBrace Therapeutics raised $85.0M.
investments
274
Diversity investments
52
Lead investments
59
Number of exits
86
Investments
274
| Annouced Date | Organization Name | Industry | Money Raised |
|---|---|---|---|
| Jan 11, 2024 | Harbor Health | Health Care | 95.5M |
| Mar 25, 2024 | Edgewood Oncology | Biotechnology | 20.0M |
| May 02, 2024 | Transcarent | Software | 126.0M |
| May 20, 2024 | Progentos Therapeutics | Life Science | 65.0M |
Exits
86
Funding Timeline
Funding rounds
274
Investors
0
Funds
2
Funding Rounds
274
Alta Partners has raised 274 rounds. Their latest funding was raised on May 20, 2024 from a Series A - Progentos Therapeutics round.
| Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
|---|---|---|---|---|
| Jan 11, 2024 | Series A - Harbor Health | - | 95.5M | - |
| Mar 25, 2024 | Series A - Edgewood Oncology | - | 20.0M | - |
| May 02, 2024 | Series D - Transcarent | - | 126.0M | - |
| May 20, 2024 | Series A - Progentos Therapeutics | - | 65.0M | - |
Investors
0
There is no funding round available on this profile
Fund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
| Annouced Date | Fund Name | Money Raised |
|---|---|---|
| May 10, 2013 | OTPPLESS | 1.0M |
| May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries
Recent Activity
There is no recent news or activity for this profile.